Lori L Hudson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lori L Hudson has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Amy P. Abernethy
Flatiron Health, New York, NY
2 shared publications - Amylou Dueck
Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, USA
2 shared publications - Arlene E. Chung
Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States
2 shared publications - Bryce B. Reeve
Department of Population Health Sciences, Duke University, Durham, North Carolina, USA
2 shared publications - Charles S. Cleeland
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
2 shared publications - Deborah Schrag
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2 shared publications
Latest Publications
- Open Access
- 16 July 2018
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 5 (3) , e10070
Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The U.S. National Cancer Institute (NCI) developed software to collect symptomatic adverse events directly from patients participating in cancer clinical trials. This software administers surveys to patients using items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) via web-based or automated telephone interfaces, and enables management of survey administration and the resultant data by professionals (clinicians and research associates). Objective: The purpose of this study was to iteratively evaluate and improve the usability of the PRO-CTCAE software in both patients and professional users. Methods: Heuristic evaluation of software functionality was followed by semi-scripted, think-aloud protocols in sequential rounds of usability testing among patients, clinicians, and research associates. Patient testing was conducted both in clinic and remotely (i.e., from home) for both the web and telephone interfaces. Software was refined between rounds and retested. Results: Heuristic evaluation identified functionality problems and deviations from best practices across 10 standardized categories, which informed initial software improvement. Subsequently, user-based testing was conducted among 169 patients with cancer (54% female, 67% white, 26% high school education or less, 19% with limited computer experience, 18% older than 65), and 47 professionals (26% physicians, 26% nurses, 49% research associates) at three cancer centers in two rounds of usability testing. Software modifications between rounds addressed identified issues, including difficulty using radio buttons, absence of survey progress indicators, and login problems (for patients); and scheduling of patient surveys (for professionals). Following modifications, there were improvements in task performance for both patients and professional users. Conclusions: Software modifications, informed by rigorous assessment, rendered a usable system which is now in use in multiple NCI-sponsored multicenter cancer clinical trials. Clinical Trial: ClinicalTrials.gov Identifier: NCT01031641
- 16 July 2018
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 5 (3) , e10070
Open AccessSoftware for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The U.S. National Cancer Institute (NCI) developed software to collect symptomatic adverse events directly from patients participating in cancer clinical trials. This software administers surveys to patients using items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) via web-based or automated telephone interfaces, and enables management of survey administration and the resultant data by professionals (clinicians and research associates). Objective: The purpose of this study was to iteratively evaluate and improve the usability of the PRO-CTCAE software in both patients and professional users. Methods: Heuristic evaluation of software functionality was followed by semi-scripted, think-aloud protocols in sequential rounds of usability testing among patients, clinicians, and research associates. Patient testing was conducted both in clinic and remotely (i.e., from home) for both the web and telephone interfaces. Software was refined between rounds and retested. Results: Heuristic evaluation identified functionality problems and deviations from best practices across 10 standardized categories, which informed initial software improvement. Subsequently, user-based testing was conducted among 169 patients with cancer (54% female, 67% white, 26% high school education or less, 19% with limited computer experience, 18% older than 65), and 47 professionals (26% physicians, 26% nurses, 49% research associates) at three cancer centers in two rounds of usability testing. Software modifications between rounds addressed identified issues, including difficulty using radio buttons, absence of survey progress indicators, and login problems (for patients); and scheduling of patient surveys (for professionals). Following modifications, there were improvements in task performance for both patients and professional users. Conclusions: Software modifications, informed by rigorous assessment, rendered a usable system which is now in use in multiple NCI-sponsored multicenter cancer clinical trials. Clinical Trial: ClinicalTrials.gov Identifier: NCT01031641
- Open Access
- 12 February 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Software for Administering the National Cancer Institute s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study (Preprint)
BACKGROUND The US National Cancer Institute (NCI) developed software to gather symptomatic adverse events directly from patients participating in clinical trials. The software administers surveys to patients using items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) through Web-based or automated telephone interfaces and facilitates the management of survey administration and the resultant data by professionals (clinicians and research associates). OBJECTIVE The purpose of this study was to iteratively evaluate and improve the usability of the PRO-CTCAE software. METHODS Heuristic evaluation of the software functionality was followed by semiscripted, think-aloud protocols in two consecutive rounds of usability testing among patients with cancer, clinicians, and research associates at 3 cancer centers. We conducted testing with patients both in clinics and at home (remotely) for both Web-based and telephone interfaces. Furthermore, we refined the software between rounds and retested. RESULTS Heuristic evaluation identified deviations from the best practices across 10 standardized categories, which informed initial software improvement. Subsequently, we conducted user-based testing among 169 patients and 47 professionals. Software modifications between rounds addressed identified issues, including difficulty using radio buttons, absence of survey progress indicators, and login problems (for patients) as well as scheduling of patient surveys (for professionals). The initial System Usability Scale (SUS) score for the patient Web-based interface was 86 and 82 (P=.22) before and after modifications, respectively, whereas the task completion score was 4.47, which improved to 4.58 (P=.39) after modifications. Following modifications for professional users, the SUS scores improved from 71 to 75 (P=.47), and the mean task performance improved significantly (4.40 vs 4.02; P=.001). CONCLUSIONS Software modifications, informed by rigorous assessment, rendered a usable system, which is currently used in multiple NCI-sponsored multicenter cancer clinical trials. CLINICALTRIAL ClinicalTrials.gov NCT01031641; https://clinicaltrials.gov/ct2/show/NCT01031641 (Archived by WebCite at http://www.webcitation.org/708hTjlTl)
- 12 February 2018
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessSoftware for Administering the National Cancer Institute s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study (Preprint)
BACKGROUND The US National Cancer Institute (NCI) developed software to gather symptomatic adverse events directly from patients participating in clinical trials. The software administers surveys to patients using items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) through Web-based or automated telephone interfaces and facilitates the management of survey administration and the resultant data by professionals (clinicians and research associates). OBJECTIVE The purpose of this study was to iteratively evaluate and improve the usability of the PRO-CTCAE software. METHODS Heuristic evaluation of the software functionality was followed by semiscripted, think-aloud protocols in two consecutive rounds of usability testing among patients with cancer, clinicians, and research associates at 3 cancer centers. We conducted testing with patients both in clinics and at home (remotely) for both Web-based and telephone interfaces. Furthermore, we refined the software between rounds and retested. RESULTS Heuristic evaluation identified deviations from the best practices across 10 standardized categories, which informed initial software improvement. Subsequently, we conducted user-based testing among 169 patients and 47 professionals. Software modifications between rounds addressed identified issues, including difficulty using radio buttons, absence of survey progress indicators, and login problems (for patients) as well as scheduling of patient surveys (for professionals). The initial System Usability Scale (SUS) score for the patient Web-based interface was 86 and 82 (P=.22) before and after modifications, respectively, whereas the task completion score was 4.47, which improved to 4.58 (P=.39) after modifications. Following modifications for professional users, the SUS scores improved from 71 to 75 (P=.47), and the mean task performance improved significantly (4.40 vs 4.02; P=.001). CONCLUSIONS Software modifications, informed by rigorous assessment, rendered a usable system, which is currently used in multiple NCI-sponsored multicenter cancer clinical trials. CLINICALTRIAL ClinicalTrials.gov NCT01031641; https://clinicaltrials.gov/ct2/show/NCT01031641 (Archived by WebCite at http://www.webcitation.org/708hTjlTl)